Home > Insider Trading > Filing (0001062993-23-022752)

Filing Details

Accession Number:: 0001062993-23-022752
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-12-18 16:36:14
Reporting Period:: 2023-12-14

Accepted Time:: 2023-12-18 16:36:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1822993	Jackson Financial Inc.	JXN	Life Insurance (6311)	980486152

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1900824	Scott Romine	1 Corporate Way Lansing MI 48951	President And Ceo, Jnld	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2023-12-14	47	$0.00	72,003	No	4	A	Direct
Common Stock	Acquisiton	2023-12-14	73	$0.00	72,077	No	4	A	Direct
Common Stock	Acquisiton	2023-12-14	147	$0.00	72,224	No	4	A	Direct
Common Stock	Acquisiton	2023-12-14	195	$0.00	72,429	No	4	A	Direct
Common Stock	Disposition	2023-12-14	5,000	$50.97	67,429	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	A	Direct
No	4	A	Direct
No	4	A	Direct
No	4	S	Direct

Footnotes

Acquired dividend equivalents in the form of Restricted Share Units ("RSUs"), which are subject to the same terms and conditions as the underlying equity granted to the recipient as part of the October 2021 Annual Grant. These RSUs vest over 30 months in three installments. The first third vested on the one-year anniversary of the grant date, October 4, 2022, the next third vested on the two-year anniversary of the grant date, October 4, 2023, and the remaining third vests on April 4, 2024. Upon vesting, full shares are distributed and fractional shares are applied to shares withheld to cover tax obligations.
Acquired dividend equivalents in the form of Restricted Share Units ("RSUs"), which are subject to the same terms and conditions as the underlying equity granted to the recipient on December 27, 2021 which reflected an adjustment to Mr. Romine's October 2021 Annual Grant, in connection with his promotion. These RSUs vest over 30 months in three equal installments. The first third vested on the one-year anniversary of the grant date, December 27, 2022, the next third vests on the two-year anniversary of the grant date, December 27, 2023, and the remaining third vests on June 27, 2024. Upon vesting, full shares are distributed and fractional shares are applied to shares withheld to cover tax obligations.
Acquired dividend equivalents in the form of Restricted Share Units ("RSUs"), which are subject to the same terms and conditions as the underlying equity granted to the recipient as part of the March 2022 Annual Grant. These RSUs vest over three years. The first third vested on the one-year anniversary of the grant date, March 10, 2023, the next third vests on the two-year anniversary of the grant date, March 10, 2024, and the remaining third vests on the three-year anniversary of the grant date, March 10, 2025. Upon vesting, full shares are distributed and fractional shares are applied to shares withheld to cover tax obligations.
Acquired dividend equivalents in the form of Restricted Share Units ("RSUs"), which are subject to the same terms and conditions as the underlying equity granted to the recipient as part of the March 2023 Annual Grant. These RSUs vest over three years, where the first third vests on the one-year anniversary of the grant date, March 10, 2024, the next third vests on the two-year anniversary of the grant date, March 10, 2025, and the remaining third vests on the three-year anniversary of the grant date, March 10, 2026. Upon vesting, full shares are distributed and fractional shares are applied to shares withheld to cover tax obligations.
The sale of shares occurred pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2023. This transaction is the final order under Mr. Romine's 10b5-1 Plan.
Shares were sold in multiple transactions, each transaction at $50.97. The reporting person undertakes to provide, upon request by Jackson Financial Inc., any security holder of Jackson Financial Inc., or the staff of the U.S. Securities and Exchange Commission, full information regarding the number of shares sold at the price set forth in this footnote.
The total reflects adjustments to correct inadvertent errors in the number of shares awarded in the March 10, 2023, equity grant, and subsequent accruals of dividend equivalent units in March, June, and September, the number of RSUs that vested on an accelerated basis on November 29, 2023, and the number of shares withheld on that date.